Improvement in Patient-reported Hearing After Treatment With Bevacizumab in People With Neurofibromatosis Type 2

Victoria Huang,Amanda L. Bergner,Chris Halpin,Vanessa L. Merker,Monica R. Sheridan,Brigitte C. Widemann,Jaishri Blakeley,Scott R. Plotkin

Improvement in Patient-reported Hearing After Treatment With Bevacizumab in People With Neurofibromatosis Type 2

2018

Victoria Huang
Amanda L. Bergner
Chris Halpin
Vanessa L. Merker
Monica R. Sheridan
Brigitte C. Widemann
Jaishri Blakeley
Scott R. Plotkin

Objective Assess patient-reported outcomes (PRO) for hearing and tinnitus relative to clinical hearing assessment in people with neurofibromatosis 2 (NF2) associated hearing loss.

Keywords:

Bevacizumab
Audiology
Tinnitus
Neurofibromatosis type 2
Medicine
Statistical significance
Hearing loss
Neurofibromatosis
Clinical trial
Distress
Referral

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations